<DOC>
	<DOC>NCT00800280</DOC>
	<brief_summary>The purpose of this study is to estimate the effects of multiple doses of cimetidine on the pharmacokinetics of a single dose of PD 0332334 and to evaluate the safety and tolerability of PD 0332334 when co-administered with cimetidine.</brief_summary>
	<brief_title>Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body</brief_title>
	<detailed_description>Detailed Description: Additional Study Purpose Details: Evaluate the effects of multiple doses of cimetidine on the pharmacokinetics (e.g., elimination from the body) of a single dose of PD 0332334. On February 18th 2009, a decision to terminate further development for PD 0332334 was communicated to investigators in this study. The decision to terminate this study was not based on any safety concerns.</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<criteria>healthy male or female adults Current or history of clinically significant medical illness Smokers Illicit drug use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics</keyword>
</DOC>